44 Soc.Sec.Rep.Ser. 460, Medicare & Medicaid Guide
P 42,408
Neil J. FARKAS, D.O.; Neil J. Farkas, D.O., P.C.,
Plaintiffs-Appellants,
v.
BLUE CROSS & BLUE SHIELD OF MICHIGAN; Secretary of Health
and Human Services, Defendants-Appellees.
No. 92-2377.
United States Court of Appeals,
Sixth Circuit.
Argued Feb. 28, 1994.
Decided May 24, 1994.
Andrеw B. Wachler, Phyllis A. Avery (argued), Detroit, MI, Gordon S. Gold (briefed), Seyburn, Kahn, Ginn, Bess & Howard, Southfield, MI, for Neil J. Farkas, D.O., PC, and Neil J. Farkas, D.O.
Edward W. Fisher, Debra A. Spicer, Detroit, MI, for Blue Cross & Blue Shield of Michigan.
Peter A. Caplan, Asst. U.S. Atty., Detroit, MI (argued and briefed), for Secretary of Health and Human Services.
Before: JONES and BOGGS, Circuit Judges; and BROWN, Senior Circuit Judge.
BAILEY BROWN, Senior Circuit Judge.
Neil J. Farkas, D.O. and Neil J. Farkas, D.O., P.C. ("Dr. Farkas") appeal the district court's dismissal of their claim against Blue Cross & Blue Shield of Michigan ("BCBSM") and the intervenor, the Secretary of Health and Human Services ("the Secretary"), arising from Dr. Farkas' being placed under Medicare Prеpayment Utilization Review ("PPUR"). The district court also vacated the Temporary Restraining Order ("TRO") that it had previously granted to prevent BCBSM from implementing PPUR for Dr. Farkas' Medicare claims. We AFFIRM both of the district court's rulings.
I.
Dr. Farkas filed on 21 December 1991 a two-count complaint in Wayne County (Michigan) Circuit Court against BCBSM, claiming (1) tortious interference with business relationship and business expectancy and (2) intentional infliction of emotional distress, both resulting from various billing and directory-listing errors committed by BCBSM, the Medicare insurance carrier for the State of Michigan. Farkas v. BCBSM,
Dr. Farkas then applied for and received from Wayne County Circuit Court a TRO to prevent BCBSM from implementing the proposed PPUR. Dr. Farkas alleged in his Motion for TRO--which has been treated by the parties, after removal to district court, as a substitute for an amended complaint--that he was placed under PPUR in retaliation for his having filed suit against BCBSM in state court.2 The Secretary then intervened and removed Dr. Farkas' case to federal district court. The district court initially granted an extension of the TRO against BCBSM. Upon motion by Dr. Farkas, the state law claims against BCBSM were remanded to state court, but the "post-Complaint PPUR claim" was severed from those claims and remained in federal court. Farkas,
There is but a single issue before us here: Did the district court have jurisdiction over Dr. Farkas' PPUR claim, when he had neither presented his claim to the Secretary nor exhausted the administrative remedies available to him prior to seeking judicial review?
II.
In reviewing a district court's dismissal of a plaintiff's complaint for lack of subject matter jurisdiction, we must assume all material facts alleged by that plaintiff to be true and construe his complaint liberally, giving him "the benefit of any doubt." Westchester Management Corp. v. HHS,
III.
A. The Medicare Act
Medicare claims are divided into two parts by the Medicare Act, 42 U.S.C. Secs. 1395-1395ccc (1988). "Part A" claims involve hospitalization coverage, while "Part B" claims are for physicians' services and related medical needs. The Secretary administers both parts; she is authorized to assign to private insurance carriers, such as BCBSM, the task of paying Part B claims from the Federal Supplementary Insurance Trust Fund ("Medicare Trust Fund"). See 42 U.S.C. Sec. 1395u; Isaacs v. Bowen,
The Medicare Act has provided, since its effective date, for a "fair hearing" by the insurance carrier for disputes over Part B claims that surpass the amount in controversy threshold, when such claims "are denied or are not acted upon with reasonable promptness" or when the amount due is in dispute. 42 U.S.C. Sec. 1395u(b)(3)(C); see also 42 C.F.R. Sec. 405.801(a). The Medicare Act has also incorporated, since its effective date, via 42 U.S.C. Sec. 1395ii, the exclusive judicial review provision of the Social Security Act, 42 U.S.C. Sec. 405(h) (1988), which prohibits an action in federal court concerning any "claim arising under" that Act when such action is brought against "the United States, the Secretary, or any officer or employee thereof" under the grant of federal jurisdiction provided in either 28 U.S.C. Sec. 1331 ("Federal question") or 28 U.S.C. Sec. 1346 ("United States as defendant"). Judicial review of Medicare claims, pursuant to Sec. 405, is only available as "herein provided"--i.e., after a final decision by the Secretary3 on a claim arising under a provision of the Medicare Act itself.
Although the Medicare Act has provided, since its effective date, for judicial review of Part A benefit claims, until 1987 it allowed no review of Part B "amount determination" claims beyond the Medicare carrier's own fair hearing. The Supreme Court so held in 1982 when it decided that claims concerning amount determinations under Part B were not subject to judicial review in the federal courts. The Court based its decision upon the language and legislative history of 42 U.S.C. Sec. 1395ff(b)(1),4 which did not at that time provide for judicial review of Part B claims. United States v. Erika, Inc.,
B. The Supreme Court
The issue before us, then, is whether the holding in Michigan Academy authorizes federal question jurisdiction over Dr. Farkas' claim under 28 U.S.C. Sec. 1331 or whether instead Dr. Farkas is bound by the requirement of 42 U.S.C. Sec. 405(g) that judicial review is available only "after [a] final deсision of the Secretary made after a hearing to which he was a party." There are four Supreme Court cases that bear directly upon the outcome here.
(a) Weinberger v. Salfi
Respondents in Salfi sought to challenge in a class action certain provisions of the Social Security Act that they claimed were unconstitutional. Weinberger v. Salfi,
(b) United States v. Erika
As discussed above, the specific grant of federal jurisdiction within the Medicare Act is contained in 42 U.S.C. Sec. 1395ff. In United States v. Erika, Inc.,
(c) Heckler v. Ringer
Ringer involved a challenge by potential Medicare beneficiaries to a policy decision by the Secretary that certain Medicare Part A claims (for a surgical procedure known as bilateral carotid body resection ("BCBR")) would no longer be reimbursed by the Medicare Trust Fund. Heckler v. Ringer,
The Court viewed Ringer's claim "as essentially one requesting the payment of benefits for BCBR surgery, a claim cognizable only under Sec. 405(g)." Id. at 620,
The Ringer Court also noted the possibility that the exhaustion prong of the Sec. 405(g) requirements might be waived under certain limited circumstances, including those in which "respondents ... raise a claim that is wholly 'collateral' to their claim for benefits." Id. at 618,
(d) Bowen v. Michigan Academy of Family Physicians
In Michigan Academy, respondents brought a constitutional challenge to the validity of a Medicare regulation. Bowen v. Michigan Academy of Family Physicians,
C. The District Court Opinion
The district court first considered Dr. Farkas' complaint in light of Michigan Academy, relying upon the distinction betweеn amount and methodology determinations, as analyzed in Kuritzky v. Blue Shield of Western New York,
As an alternative ground for dismissing Dr. Farkas' complaint, the district court held that "the amount/methodology dichotomy is no longer relevant, and Michigan Academy is of no continuing precedential value." Id. at 94 (citing National Kidney Patients Ass'n v. Sullivan,
IV.
Dr. Farkas argues that Michigan Academy is still good law, even after the 1986 amendment to the Medicare Act, and that it controls the outcome of his appeal. He contends that even though judicial review of Part B amount determinations is now available, after the presentment and exhaustion requirements of 42 U.S.C. Sec. 405(g) have been satisfied, his claim here is one challenging thе methodology of Part B determinations, for which Michigan Academy still provides direct federal-question jurisdiction. He characterizes his claim as one "challenging the regulation that gives the Secretary the unbridled discretion to place him on PPUR on arbitrary and capricious grounds.... This is not an amount dispute but one over the methodology used by the Secretary to place providers on PPUR." He considers PPUR to be "a severe form of punishment " that "consistently results in denied claims which necessitate 'amount' hearings." He argues that he has а constitutional challenge in that the Secretary placed him under PPUR "solely [out] of vindictiveness," in retaliation for his lawsuit against BCBSM, which "sanction is extremely repugnant to basic due process requirements."
Dr. Farkas reasons that there is no conflict between Michigan Academy and Ringer because the latter was not a "methods" case, as asserted by the court in National Kidney, but rather an amount determination case, thus leaving open the possibility that Michigan Academy survives the 1986 amendment to Sec. 1395ff and applies to methodоlogy claims under both Parts A and B. It is incorrect, however, to distinguish Ringer and Michigan Academy on this basis, since both cases involved challenges to policy determinations of the Secretary.
Dr. Farkas cites our holding in Westchester to support the proposition that the reasoning of Michigan Academy now applies to methodology challenges to Part A regulations, and not just to such challenges to Part B regulations. His argument thus accepts the premise that Part A and Part B claims must be treated identically after the 1986 amendments. See National Kidney,
A study of Westchester reveals, however, that "the Michigan Academy exception appliеs only when there is no other avenue of judicial review" available to a plaintiff.
Dr. Farkas argues that waiver of the exhaustion requirement for review of administrative action applies to the circumstances of his claim. This argument, however, misses the point that presentment of a claim to the Secretary is a nonwaivable requirement for judicial review under Sec. 405(g). If Dr. Farkas must meet the twin prerequisites of Sec. 405(g), then whether exhaustion might be waived is immaterial here, since he has failed to meet the presentment requirement. If Dr. Farkas can bypass Sec. 405(g), which we hold he cannot, exhaustion again is not an issue, because the exhaustion of administrative remedies is not a prerequisite to federal-question jurisdiction in the federal courts.
Finally, Dr. Farkas argues that the federal courts have jurisdiction over his claim under the Administrative Procedures Act ("the APA"), 5 U.S.C. Sec. 702 (1988). The Supreme Court, however, rejected a similar argument in Ringer, relying upon Salfi:
Ringer's claim may well "aris[e] under" the APA in the same sense that Salfi's claim arose under the Constitution, but we held in Salfi that the constitutional claim was nonetheless barred by Sec. 405(h). It would be anomalous indeed for this Court ... to give greater solicitude to an APA claim than the Court thought the statute allowed it to give to the constitutional claim in Salfi.
Ringer,
V.
We reject Dr. Fаrkas' argument that the amount/methodology distinction of Michigan Academy is still good law; the OBRA amendments to the Medicare Act have deprived Michigan Academy of lasting precedential value. The National Kidney court, considering a post-amendment challenge to a Part B regulation that clearly fell into the "methodology" category, held that all claims under Medicare Part B are now to be treated in the same manner as Medicare Part A and Social Security claims. Because "persons affected by an advеrse decision of a[n insurance] carrier may now obtain review by the Secretary," National Kidney,
Since claims under Medicare Parts A and B are now to be treated in identical fashion, a holding that a party may bring a methodology claim under Part B directly to federal district court, without having first presented a claim to the Secretary for a final decision, would mean that we would have to grant fеderal-question jurisdiction to a methodology claim under Part A of Medicare as well. This would in effect be a holding that Michigan Academy overrules the entire line of Supreme Court cases that has denied direct federal-question jurisdiction to claims under Part A. See National Kidney,
Our decision here, оf course, does not permanently close the federal courts to Dr. Farkas' PPUR claim. Dr. Farkas may challenge BCBSM's PPUR decision in conjunction with a claim for any payments denied by BCBSM because of his failure to comply with the PPUR requirements. If and when BCBSM rejects such a challenge to its PPUR decision and fails to pay his claims because he did not comply with PPUR, Dr. Farkas may then seek review of that decision via the appeals process available within the Department of Health and Human Services and ultimately from the federal courts. If the district court then rules that the decision to place Dr. Farkas under PPUR was improper, it can issue the appropriate relief.
VI.
For the reasons stated above, namely, that Dr. Farkas' challenge to his PPUR status arises under the Medicare Act and is amenable to judicial review only after the Sec. 405(g) dual requirements of presentment and exhaustion have been satisfied, we AFFIRM the decision of the district court dismissing plaintiff's claim for lack of subject matter jurisdiction and dissolving the TRO against BCBSM.
Notes
Medicare insurance carriers conduct either postpayment audits or prepayment reviews of the claims from their service providers. According to the Medicare Carrier's Manual:
"The primary goal of prepayment utilization screening is to ensure that Medicare pays only for medically necessary services.... Prepayment controls ... [allow the carrier to better monitor] services provided by problem providers before a claim is processed."
Farkas,
On appeal, however, he broadened his attack, without objection from the appellees, to include the contention that the PPUR program under its existing implementation is unconstitutional and that, in any event, it was unconstitutional to apply it to him under these circumstances. We herein determine that the decision by the district court must be affirmed regardless of the precise nature of Dr. Farkas' claim
42 U.S.C. Sec. 405(g) (1988) provides judicial review for "[a]ny individual, after any final decision of the Secretary made after a hearing to which he was a party, irrespective of the amount in controversy." (Emphasis added)
42 U.S.C. Sec. 1395ff(b)(1) (1982) provided, prior to its 1986 amendment, for "judicial review of the Secretary's final decision after such hearing as is provided in section 405(g)" for:
Any individual dissatisfied with any determination under subsection (a) of this section as to--... (C) the amount of benefits under part A of this subchapter (including a determination where such amount is determined to be zеro).
(Emphasis added).
42 U.S.C. Sec. 1395ff(b)(1)(C) was amended to provide judicial review for challenges to the determination of "the amount of benefits under part A or part B of this subchapter." (Emphasis added). See supra n. 4 (containing the pre-amendment version of this subsection). 42 U.S.C. Sec. 1395ff(b)(2)(B) provides an amount in controversy threshold of $500 for administrative review and of $1000 for judicial review of Part B claims
As indicated supra at n. 2, Dr. Farkas has on appeal broadened his attack to include a constitutional basis for his claim
Because we so hold, we need not consider the first ground presented by the district court for its decision, namely, that Dr. Farkas did not in fact bring a "methodology" claim against BCBSM and the Secretary
